Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004. [electronic resource]
Producer: 20130927Description: 1884-93 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers -- blood
- Breast Neoplasms -- blood
- Capecitabine
- Dasatinib
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Pyrimidines -- administration & dosage
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.